Repligen
Price & Volume
Stats
See more52W Range | $102.96-$182.52 |
Market Cap | $6.9B |
Shares Short | 3M |
Financials
See moreRevenue (12 Mos) | $673.9M |
Revenue Growth (YoY) | 14.8% |
Gross Profit (12 Mos) | $343.6M |
Diluted EPS | -$0.25 |
News
See moreYahoo Finance • last month
Repligen Corporation to Present at Upcoming September Conferences
Yahoo Finance • 2 months ago
Repligen partners with Novasign to enhance bioprocessing systems
Yahoo Finance • 2 months ago
Repligen Announces Strategic Partnership with Novasign to Further Advance Bioprocessing Digitalization
Yahoo Finance • 2 months ago
Repligen Corp (NASDAQ:RGEN) Q2 2025 Earnings: Revenue Beat Offsets EPS Miss as Stock Rises in Pre-Market
About
CEO | Mr. Olivier Loeillot |
CFO | Mr. Jason K. Garland |
Address | Building 1, Waltham, MA, United States, 02453 |
Sector | Healthcare |
Industry | Medical Instruments & Supplies |
Full-Time Employees | 1,778 |
